EP01.66: Additive manufacturing in fetal medicine and the general data protection law

To emphasise the importance of the General Data Protection Law (GDPL) when we use Additive Manufacturing (AM) technology in fetal medicine cases. Images from 47 cases, including 5 sets of twins, were used. Scans were performed using high-resolution 3D ultrasound (3DUS). Magnetic resonance imaging (MRI) was performed on the same day as 3DUS. The AM technologies used were Ultimaker (USA), Formlabs Form 3 Plus (Somerville, MA, USA) and MediJet J5 Stratasys (USA). AM technology was successfully generated. A consent form was signed by the patient explaining all the technology and reaffirming the complete anonymity of the images. All patients felt safe when they received informed consent reaffirming the use of the LGPD. AM commonly known as 3D printing allows accurate physical reproduction of fetal anatomy from 3DUS and MRI. GDPL started in Brazil in 2020. It is responsible for major changes in how personal data is handled and determines standards and rules for the collection, use, treatment, and proper storage of personal information. AM has a potential to aid students and a healthcare multidisciplinary team improving the collaboration and understanding of complex fetal malformations. GDPL must always be considered in the face of all these studies. It applies to processing operations that take place throughout the country, but also to outside the country, when personal data are collected.